{"disease":{"id":"bladder-urothelial-transitional-cell-cancer-metastatic-or-unresectable","name":"bladder urothelial transitional cell cancer metastatic or unresectable"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06820255","title":"DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06880757","title":"177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Ankara University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}